Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-088387
Filing Date
2023-08-07
Accepted
2023-08-07 16:41:14
Documents
6
Effectiveness Date
2023-08-07

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2322563d1_s8.htm S-8 71926
2 EXHIBIT 5.1 tm2322563d1_ex5-1.htm EX-5.1 8631
3 EXHIBIT 23.2 tm2322563d1_ex23-2.htm EX-23.2 2643
4 EX-FILING FEES tm2322563d1_ex-filingfees.htm EX-FILING FEES 14810
5 GRAPHIC tm2322563d1_ex5-1img001.jpg GRAPHIC 1855
6 GRAPHIC tm2322563d1_ex5-1img002.jpg GRAPHIC 6149
  Complete submission text file 0001104659-23-088387.txt   110478
Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-273773 | Film No.: 231148137
SIC: 2834 Pharmaceutical Preparations